ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1029

Virtual Assessment in Axial Spondyloarthritis: Validation of Video Observation of Spinal Metrology

Laura Passalent1, Sareh Keshavarzi1, Robert Inman1 and Nigil Haroon2, 1University Health Network, Toronto, ON, Canada, 2Schroeder Arthritis Institute, University Health Network; University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Measurement, Spondyloarthropathies

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: A shift to virtual clinical encounters was required because of the COVID-19 pandemic. To date, there have been few studies exploring the utility of virtual examination of spinal mobility for patients with axial spondyloarthritis (axSpA) with varying reports of validity and reliability. The purpose of this study was to evaluate the validity of observed spinal mobility measures over live video in the assessment of patients with established axSpA.

Methods: Adult patients diagnosed with axSpA based on ASAS criteria, attending an urban academic Spondylitis Program and registered in the program’s longitudinal research cohort were scheduled for a virtual video follow-up visit. Patients conducted spinal mobility maneuvers based on standardized verbal direction by the attending clinician. Spinal measures were visually estimated by the clinician observer and included tragus to wall distance, cervical spinal rotation, lumbar lateral flexion and intermalleolar distance. The modified Schober’s maneuver to assess degree of lumbar flexion was converted to categorical variables based on normative values and was compared to estimated impairment of observed finger to floor distance (FFD) (i.e. normal, mild, moderate and severe impairment). Spinal measures were compared to patients’ last in-person visit within a 24-month period. Concurrent validity of the virtual spinal measures was estimated based on correlation (Pearson’s correlation coefficient) to previous in-person Bath Ankylosing Spondylitis Metrology Index (BASMI) scores (10-step analysis) and its individual components. Differences in lumbar flexion measures (modified Schober’s and FFD) were evaluated using Chi Square test. Construct validity was assessed against the previous Bath Ankylosing Spondylitis Functional Index (BASFI), reflecting constructs of mobility and function.

Results: A total of 37 patients underwent virtual examination of spinal mobility. Approximately half were female (51.3%); mean age of 28.4 years (± 11.9); mean disease duration 13.6 years (±10.5); mean Bath Ankylosing Spondylitis Disease Activity Index was 4.1 (±2.5); 29.7% were receiving biologic treatment; 51.3% were receiving non-steroidal anti-inflammatories. Five clinical observers assessed participants (3 rheumatology fellows; 1 advance practice physiotherapist and 1 rheumatology resident). Average time between last in-person measure and virtual measure was 21.5 months (±6.5). Virtual BASMI scores were highly correlated with previous in-person BASMI score (r=0.75). Virtual component BASMI measures ranged from r=0.57 (lumbar lateral flexion) to r=0.79 (cervical rotation) compared to in-person measures. Estimation of lumbar flexion impairment of virtually observed FFD was not statistically different from in-person modified Schober’s maneuver (p=0.46). Virtual BASMI scores were moderately correlated with the BASFI (r=0.61).

Conclusion: The results of this study suggest spinal mobility measures conducted over live video and conducted by an experienced clinician in rheumatology assessment are a valid substitution for in-person measurement.


Disclosures: L. Passalent, UCB, Novartis, AbbVie/Abbott; S. Keshavarzi, None; R. Inman, Novartis, Janssen, AbbVie/Abbott, Eli Lilly, Aria Pharmaceuticals, Amgen, Pfizer, Sandoz; N. Haroon, AbbVie/Abbott, Janssen, Eli Lilly, Novartis, UCB.

To cite this abstract in AMA style:

Passalent L, Keshavarzi S, Inman R, Haroon N. Virtual Assessment in Axial Spondyloarthritis: Validation of Video Observation of Spinal Metrology [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/virtual-assessment-in-axial-spondyloarthritis-validation-of-video-observation-of-spinal-metrology/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/virtual-assessment-in-axial-spondyloarthritis-validation-of-video-observation-of-spinal-metrology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology